Andexxa 200 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCT8T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,132
Award facts
- Contract value 100% obligated
- $20,131.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ANDEXXA 200 mg vials, valued at $20,131.92 under a firm fixed price contract type. The award, announced on December 9, 2025, with an ultimate completion date of December 31, 2025, carries no set-aside designation, indicating competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. ANDEXXA is a reversal agent used in emergency medical settings to counteract the effects of certain anticoagulant medications, making it a critical pharmaceutical for military medical supply chains supporting trauma and emergency care capabilities.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established position as a major pharmaceutical distributor and federal medical procurement vendor demonstrates its capability to meet specialized emergency pharmaceutical needs across the Defense Health Agency and other government healthcare systems through this flexible contract framework.
Quick answers
Who was awarded contract SPE2DR26FCT8T?
SPE2DR26FCT8T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FCT8T worth?
The government has obligated $20,132 on SPE2DR26FCT8T.
Is contract SPE2DR26FCT8T an order under another contract?
Yes. SPE2DR26FCT8T is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT8T competed?
The extent of competition for SPE2DR26FCT8T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award